PRINCIPAL FINANCIAL GROUP INC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1126328
DES MOINES, IA
Position in REGN
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$75,481,386
-$17,563,785 QoQ
Shares Held
121,053
+0.5% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#101
of 1,327 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,852,088,599 across 105 Biotechnology names. REGN ranks #8 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
121,053 | $75,481,386 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $75,481,386 | 121,053 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $93,045,171 | 120,425 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $92,334,948 | 119,625 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $66,619,436 | 118,483 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $64,705,725 | 123,249 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $82,212,063 | 129,625 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $92,951,941 | 130,490 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $181,961,233 | 173,092 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $178,952,571 | 170,264 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $162,094,865 | 168,412 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $114,816,216 | 130,727 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $108,099,910 | 131,355 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $95,585,220 | 133,027 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $111,967,326 | 136,268 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $97,151,514 | 134,654 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $99,494,182 | 144,431 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $76,532,418 | 129,468 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $88,102,190 | 126,145 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $79,496,369 | 125,881 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $77,642,172 | 128,296 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $70,160,443 | 125,614 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $62,411,897 | 131,910 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $68,543,646 | 141,880 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $82,934,205 | 148,155 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $94,652,607 | 151,772 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $57,461,478 | 117,679 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||